Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 8:33 AM UTC
| NCT Number | NCT06941272 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT06941272 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 17 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06941272 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06941272 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.